| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aims ; scope/editorial board
|
|
|
2004
|
17 |
4 |
p. iii-
1 p.
|
artikel
|
| 2 |
DNA methyltransferase inhibitors in myelodysplastic syndrome
|
Silverman, Lewis R.
|
|
2004
|
17 |
4 |
p. 585-594
10 p.
|
artikel
|
| 3 |
Histone deacetylase inhibitors in myelodysplastic syndrome
|
Bhalla, Kapil
|
|
2004
|
17 |
4 |
p. 595-611
17 p.
|
artikel
|
| 4 |
Immunobiologic therapies for myelodysplastic syndrome
|
Appelbaum, Frederick R
|
|
2004
|
17 |
4 |
p. 653-661
9 p.
|
artikel
|
| 5 |
Inhibitors of signaling in myelodysplastic syndrome
|
Gore, Steven D.
|
|
2004
|
17 |
4 |
p. 613-622
10 p.
|
artikel
|
| 6 |
Modulation of angiogenesis in patients with myelodysplastic syndrome
|
Estey, Elihu H.
|
|
2004
|
17 |
4 |
p. 623-639
17 p.
|
artikel
|
| 7 |
Modulation of drug resistance transporters as a strategy for treating myelodysplastic syndrome
|
Ross, Douglas D.
|
|
2004
|
17 |
4 |
p. 641-651
11 p.
|
artikel
|
| 8 |
Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome
|
Foss, Francine M.
|
|
2004
|
17 |
4 |
p. 573-584
12 p.
|
artikel
|
| 9 |
Pathobiology, classification, and diagnosis of myelodysplastic syndrome
|
Mufti, Ghulam J.
|
|
2004
|
17 |
4 |
p. 543-557
15 p.
|
artikel
|
| 10 |
State of the science for myelodysplastic syndrome: prognosis and promise of new therapies
|
Rowe, Jacob M.
|
|
2004
|
17 |
4 |
p. 535-541
7 p.
|
artikel
|
| 11 |
Subject index for 17/4
|
|
|
2004
|
17 |
4 |
p. I-III
nvt p.
|
artikel
|
| 12 |
Transplant strategies for myelodysplastic syndrome
|
McCarty, John
|
|
2004
|
17 |
4 |
p. 559-572
14 p.
|
artikel
|
Tijdschrift beschrijving